<DOC>
	<DOCNO>NCT01287689</DOCNO>
	<brief_summary>This non-interventional , epidemiological study assess long-term outcome subject receive immunoglobulin ( IgG ) treatment purpose , irrespective regimen prescribe treat physician , routine clinical condition among least 550 subject Germany . Long-term outcome data collect patient characteristic various indication , drug utilization intravenous subcutaneous IgG ( e.g . treatment dose pattern ) , effectiveness ( i.e . number infection ) , tolerability , health relate quality life , economic variable ( number hospitalization , sick-leave day etc . ) possibility estimate direct cost .</brief_summary>
	<brief_title>Assessment Immunoglobulins ( IgG ) Long-term Non-interventional Study</brief_title>
	<detailed_description>In view broad range indication immunodeficiency immunomodulation , interest document use IgG condition everyday practice analyze endpoint ( outcome ) . A prospective cohort study important evidence source rare disease mention . The aim outcome study fill gap lack long-term data rare disease treat IgG .</detailed_description>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Immunologic Deficiency Syndromes</mesh_term>
	<mesh_term>Autoimmune Diseases</mesh_term>
	<mesh_term>Immunoglobulins</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<mesh_term>Immunoglobulin G</mesh_term>
	<criteria>Subjects either gender primary , severe secondary immunodeficiency recurrent infection neurological autoimmune disease Na√Øve IgG , pretreated IgG Subject parent/legally authorize representative provide write informed consent .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Non-interventional trial</keyword>
	<keyword>immunodeficiency</keyword>
	<keyword>outcome study , registry</keyword>
	<keyword>long-term outcome , drug utilization</keyword>
	<keyword>effectiveness , treatment pattern</keyword>
	<keyword>patient characteristic real life condition</keyword>
	<keyword>factor treatment success</keyword>
	<keyword>long-term tolerability</keyword>
	<keyword>quality life</keyword>
</DOC>